Previous Close | 73.00 |
Open | 73.00 |
Bid | 80.50 |
Ask | 84.50 |
Strike | 200.00 |
Expire Date | 2024-12-20 |
Day's Range | 73.00 - 73.00 |
Contract Range | N/A |
Volume | |
Open Interest | 10 |
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.